Importantly, the approach allowed usto identify synergistic and pre-sensitizing drugs that have the potential toincrease FLT3 inhibitor treatment efficacy in FLT3-ITD-positive AML by preventingemergence of treatment resistance. This evidence concerns the gene FLT3 and acute myeloid leukemia.